BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31689674)

  • 1. The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.
    Namazov A; Gemer O; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Lavie O; Amit A; Levy T; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Ben-Arie A
    Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():120-124. PubMed ID: 31689674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
    Gemer O; Segev Y; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Ben Arie A; Amit A; Levy T; Namazov A; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Lavie O
    Am J Obstet Gynecol; 2018 Aug; 219(2):181.e1-181.e6. PubMed ID: 29792852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group study.
    Namazov A; Helpman L; Eitan R; Vaknin Z; Lavie O; Amit A; Levy T; Shachar IB; Atlas I; Bruchim I; Arie AB; Gemer O
    Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():67-71. PubMed ID: 38118271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of fallopian tube cytology: a study of 99 endometrial malignancies.
    Mulvany NJ; Arnstein MB; Ryan VA
    Pathology; 2000 Feb; 32(1):5-9. PubMed ID: 10740797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
    Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature of early-stage endometrial cancer recurrence-A national cohort study.
    Jeppesen MM; Jensen PT; Gilså Hansen D; Iachina M; Mogensen O
    Eur J Cancer; 2016 Dec; 69():51-60. PubMed ID: 27816832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
    Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
    Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
    Xu MJ; Chu C; Rubin S; Lin LL
    Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
    Philp L; Tannenbaum S; Haber H; Saini A; Laurent JS; James K; Feltmate CM; Russo AL; Growdon WB
    Gynecol Oncol; 2021 Feb; 160(2):389-395. PubMed ID: 33358198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.
    Brasky TM; Felix AS; Cohn DE; McMeekin DS; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Park KJ; Ali S; Brinton LA
    J Natl Cancer Inst; 2017 Mar; 109(3):1-10. PubMed ID: 28376204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.
    Altman AD; Ferguson SE; Atenafu EG; Köbel M; McAlpine JN; Panzarella T; Lau S; Gien LT; Gilks B; Clarke B; Cameron A; Nelson G; Han G; Samouëlian V; Ho TC; Louie K; Bernardini MQ
    Gynecol Oncol; 2015 Nov; 139(2):268-74. PubMed ID: 26352641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
    Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
    Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and treatment of endometrial cancer: progress and controversies.
    Denschlag D; Ulrich U; Emons G
    Dtsch Arztebl Int; 2010 Aug; 108(34-35):571-7. PubMed ID: 21904591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
    Yoon MS; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Lee KK; Kim M; Jeong JU; Chang SK; Park W
    Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.
    Loizzi V; Cormio G; Lorusso M; Latorre D; Falagario M; Demitri P; Scardigno D; Selvaggi LE
    Eur J Cancer Care (Engl); 2014 May; 23(3):380-4. PubMed ID: 24112088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysteroscopic morphological pattern reflects histological grade of endometrial cancer.
    Miyamoto T; Abiko K; Murakami R; Furutake Y; Baba T; Horie A; Hamanishi J; Mandai M
    J Obstet Gynaecol Res; 2019 Aug; 45(8):1479-1487. PubMed ID: 31074203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
    Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
    Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.